Multimodal imaging features of retroperitoneal anastomosing hemangioma: a case report and literature review

Liqing Zhang, Jian WuFrontiers in Oncology 2023 · DOI

Abstract

Retroperitoneal anastomosing hemangioma (AH) is an exceedingly rare, benign vascular neoplasm that frequently mimics aggressive malignancies such as angiosarcoma or ectopic pheochromocytoma in clinical imaging. This diagnostic ambiguity often leads to high-risk, unnecessary radical surgeries. This report presents a detailed case study and a comprehensive literature review to define a multimodal imaging "signature" for AH. Characterized by progressive centripetal filling and specific enhancement patterns across CT, MRI, and ultrasound, this signature serves as a vital tool for clinicians to differentiate this benign entity from its malignant counterparts.

Introduction

Anastomosing hemangioma is a unique histological subtype of capillary hemangioma, first described in the genitourinary tract. When it manifests in the retroperitoneum—the anatomical space behind the abdominal cavity—it presents a formidable diagnostic challenge. Because these tumors are highly vascularized, they often exhibit imaging characteristics that suggest malignancy. Radiologists frequently misinterpret these features, leading to diagnoses of angiosarcoma (a highly aggressive vascular cancer) or ectopic pheochromocytoma (a hormone-secreting tumor). The primary objective of this study is to bridge the gap between radiological observation and pathological reality by identifying consistent imaging features that point toward a benign AH diagnosis before surgical intervention.

Methods and Multimodal Imaging Approach

To characterize the imaging features of retroperitoneal AH, the authors utilized a two-pronged investigative approach. First, they documented the diagnostic journey of a 57-year-old female patient using a variety of imaging modalities. Second, they conducted a literature review of approximately 30 previously reported cases of retroperitoneal AH, specifically analyzing seven pathologically proven cases to identify common radiological denominators.

Computed Tomography (CT) Findings

The primary patient underwent a multi-phase CT protocol, including plain, arterial, and venous phases. Plain CT scans revealed a well-defined, relatively low-density mass (13–25 Hounsfield Units). Upon administration of intravenous contrast, the tumor demonstrated intense enhancement, with density values jumping to a peak of 174 HU during the arterial phase.

A critical diagnostic feature observed was progressive centripetal filling. Similar to cavernous hemangiomas of the liver, contrast medium initially enters the periphery of the mass and gradually migrates toward the center in subsequent phases.

Contrast-enhanced CT scan (arterial phase) demonstrating the intense vascular enhancement characteristic of retroperitoneal anastomosing hemangioma.

Ultrasound and MRI Characteristics

The multimodal assessment continued with Contrast-Enhanced Ultrasound (CEUS) and Magnetic Resonance Imaging (MRI). On CEUS, the tumor exhibited a "slow-in and slow-out" enhancement pattern. This is a significant differentiator, as many malignant vascular tumors typically show a rapid "washout" of contrast. Color Doppler imaging further confirmed the lesion's rich internal vascularity.

Color Doppler ultrasound image showing significant internal blood flow within the hypoechoic retroperitoneal mass, supporting the diagnosis of a vascular tumor.

MRI provided additional "signal signatures." The lesion typically presented with low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. While Diffusion-Weighted Imaging (DWI) showed slightly high intensity, it did not exhibit the severe water molecule restriction characteristic of dense, highly cellular malignancies.

Literature Review and Key Insights

The authors' review of 30 cases published between 2009 and 2022 revealed several key insights into the nature of retroperitoneal AH:

  • Demographic Trends: The condition appears more prevalent in older populations, with a median age of 65 for extrarenal cases and approximately 67 for retroperitoneal cases.
  • Pathological Markers: Definitive diagnosis is confirmed via histopathology, which typically shows a "honeycomb" of interconnected blood vessels lined by a single layer of endothelial cells. These cells consistently test positive for vascular markers CD31 and CD34.
  • Prognostic Outlook: AH carries an excellent prognosis. In the reported case, the patient remained recurrence-free during a 40-month follow-up period, reinforcing the benign nature of the tumor.

Conclusion and Future Directions

While the rarity of retroperitoneal anastomosing hemangioma makes establishing a definitive "radiological gold standard" difficult, the identification of a multimodal imaging signature—including intense arterial enhancement, centripetal filling, and specific MRI signals—offers a path toward more accurate pre-operative diagnosis.

The authors suggest that as clinical awareness and documentation of these features increase, management strategies may shift. In the future, a "watch and wait" approach or less invasive biopsies could potentially replace major surgical resections for suspected AH. Further research into advanced techniques like radiomics or texture analysis may provide even greater specificity in distinguishing AH from its malignant look-alikes, ultimately improving patient outcomes and reducing surgical morbidity.

Summary updated

Abstract

Retroperitoneal anastomotic hemangioma is a rare and benign neoplasm that may be misdiagnosed as ectopic pheochromocytoma or angiosarcoma. This case report presents and analyzes the imaging characteristics of a series of retroperitoneal anastomotic hemangiomas, which can be valuable for future diagnoses and help prevent unnecessary surgeries.
BibTeX
@inproceedings{zhang2023multimodal,
  author = {Liqing Zhang and Jian Wu},
  title = {{Multimodal imaging features of retroperitoneal anastomosing hemangioma: a case report and literature review}},
  booktitle = {Frontiers in Oncology},
  year = {2023},
  doi = {10.3389/fonc.2023.1269631},
}
Figure